NEUR NeuroSearch A/S

Major shareholder announcement

Major shareholder announcement



Company announcement

23 July 2019







Major shareholder announcement

Pursuant to section 30 of Consolidated Act no. 459 of 24 April 2019 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major shareholder announcement from Nordic Transport Group Holding A/S ("NTG Holding").

NTG Holding has informed NeuroSearch that NTG Holding today 23 July 2019 has purchased 13,266 shares of nominally DKK 20 in NeuroSearch.

Upon the purchase, NTG Holding holds 407,885 shares of nominally DKK 20 in NeuroSearch corresponding to 33.37 percent of the total share capital and voting rights in NeuroSearch.

Other information

As previously informed in company announcements of 5 April 2019 and 9 July 2019, NeuroSearch and Nordic Transport Group A/S ("NTG") have signed a non-binding letter of intent contemplating (i) the combination of NeuroSearch and NTG to be effected by the contribution into NeuroSearch of all shares in NTG (as well as shares in some of its subsidiaries) against the issuance of new shares in NeuroSearch to the shareholders in NTG, and (ii) the offering of shares to new investors (the "Transaction"). It is the intention that the Transaction will be completed in Q4 2019. NTG is a related company to NTG Holding.

Please note that under the rules for issuers of shares, the Transaction will qualify as a "change of identity", see clause 2.9 of the rules. Nasdaq Copenhagen A/S ("Nasdaq") has informed NeuroSearch that Nasdaq will assess whether upon completion of the Transaction NeuroSearch may keep its stock exchange listing following the change of identity. Nasdaq has informed NeuroSearch also that it will begin a process to evaluate whether the shares of NeuroSearch may continue to be admitted to trading, unless in all material respects NeuroSearch adheres to the model for a combination with NTG in accordance with the timetable referred to above.

Mikkel Primdal Kæregaard                                    Allan Andersen

Chairman of the Board of Directors                       CEO



Contact person

Allan Andersen, CEO, mobile phone .



About NeuroSearch

NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.



Attachment

EN
23/07/2019

Underlying

NEURNeuroSearch A/S

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NeuroSearch A/S

 PRESS RELEASE
Free
NEUR NEUROSEARCH A/S

Major shareholder announcement

Major shareholder announcement Company announcement no 33 - 19 7 October 2019 Major shareholder announcement With reference to company announcement no 30 - 19 on 7 October 2019 regarding completion of the Transaction, NTG Nordic Tranasport Group A/S (“NTG”) hereby announces in accordance with section 30 of Consolidated Act no. 931 of 6 September 2019 on capital markets, as amended, to have received the following announcements from major shareholders in NTG.  Nordic Transport Group Holding A/SNordic Transport Group Holding A/S, CVR-no. 39569779, has informed that it as of today ...

October 7, 2019 1 EN
 PRESS RELEASE
Free
NEUR NEUROSEARCH A/S

Update of financial calendar 2019

Update of financial calendar 2019 Company announcement no 32 - 19 7 October 2019 Update of financial calendar 2019 NTG Nordic Transport Group A/S announces to have updated its financial calendar for 2019: 27 November 2019                                  Interim report for the first nine months of 2019 The interim report will be available on the company's website immediately after its release. Additional information For additional information, please contact: Christian Jakobsen, CFO                                                                                                 ...

October 7, 2019 1 EN
 PRESS RELEASE
Free
NEUR NEUROSEARCH A/S

Result of the Extraordinary General Meeting as well as change of Execu...

Result of the Extraordinary General Meeting as well as change of Executive Management, updated financial calendar and issue of warrants Company announcement no 31 - 19 7 October 2019 Result of the Extraordinary General Meeting as well as change of Executive Management, updated financial calendar and issue of warrants Result of the Extraordinary General Meeting At the Extraordinary General Meeting the following was resolved: ·The proposal to reduce the company's share capital by DKK 7.00 by provision to a special reserve and to amend Article 3 of the Articles of Association was adopted ...

October 7, 2019 1 EN
 PRESS RELEASE
Free
NEUR NEUROSEARCH A/S

Issue of new shares and completion of the Transaction

Issue of new shares and completion of the Transaction Company announcement no 30 - 19 7 October 2019 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. This announcement does not constitute a prospectus and nothing herein contains an offering of securities. Issue of new shares and completion of the Transaction With reference to company announcement no 28 - 19 regarding cancellation of offering and company announ...

October 7, 2019 1 EN
 PRESS RELEASE
Free
NEUR NEUROSEARCH A/S

Publication of supplement

Publication of supplement Company announcement no 29 - 19 7 October 2019 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. This announcement does not constitute a prospectus and nothing herein contains an offering of securities. Publication of supplement With reference to company announcement no 26 - 19 of 24 September 2019 concerning publication of a prospectus and company announcement no 28 - 19 of 7 October...

October 7, 2019 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch